Cargando…
Engineering Non-Human RNA Viruses for Cancer Therapy
Alongside the development and progress in cancer immunotherapy, research in oncolytic viruses (OVs) continues advancing novel treatment strategies to the clinic. With almost 50 clinical trials carried out over the last decade, the opportunities for intervention using OVs are expanding beyond the old...
Autores principales: | Tur-Planells, Vicent, García-Sastre, Adolfo, Cuadrado-Castano, Sara, Nistal-Villan, Estanislao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611381/ https://www.ncbi.nlm.nih.gov/pubmed/37897020 http://dx.doi.org/10.3390/vaccines11101617 |
Ejemplares similares
-
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
por: García-Romero, Noemi, et al.
Publicado: (2020) -
Species-Specific Inhibition of RIG-I Ubiquitination and IFN Induction by the Influenza A Virus NS1 Protein
por: Rajsbaum, Ricardo, et al.
Publicado: (2012) -
Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines
por: Manicassamy, Balaji, et al.
Publicado: (2010) -
Immune responses elicited by ssRNA(−) oncolytic viruses in the host and in the tumor microenvironment
por: Bykov, Yonina, et al.
Publicado: (2023) -
Interferon-β Stimulation Elicited by the Influenza Virus Is Regulated by the Histone Methylase Dot1L through the RIG-I-TRIM25 Signaling Axis
por: Marcos-Villar, Laura, et al.
Publicado: (2020)